COVID-19: Research to address the pandemic
Manchester's COVID-19 research rapid response group
Manchester scientists have established a COVID-19 research rapid response group to bring together the research and innovation strengths of our clinical-academic partnerships in an unprecedented way to focus on this public health crisis.
Scientists within The University of Manchester’s Faculty of Biology, Medicine and Health are working with NHS colleagues from Manchester University NHS Foundation Trust and the Northern Care Alliance NHS Group, supported by Health Innovation Manchester, and utilising our experimental and translational research expertise through the NIHR Manchester Biomedical Research Centre and NIHR Manchester Clinical Research Facility.
This brings together the research and innovation strengths of our partnerships in an unprecedented way to focus on this public health crisis. The aims of the COVID-19 research rapid response group are to minimise lives lost nationally and globally, and reduce the impact of the pandemic on Greater Manchester’s health and social care system and the wider community.
The group’s work is focusing on a number of key priorities:
- New treatments
- Disease mechanisms
- Patient assessment
- Social care impact
- Patients with existing health conditions
- Rapid diagnosis
We will update this webpage with more information as the work progresses.